Blog Where innovation, insight & ideas combine. Contact Us Ask The Experts Home Blog Translational Pharmaceutics, Dr. Helen Baker, Dr. Vanessa Zann, Drug Development Consulting, Drug Product, Philadelphia, Miami Accelerating Drug Development with Translational Pharmaceutics® Read Now Categories View all categories14C Radiolabeling505(b)(2)AlnwickBioanalysisBiopharmaceuticsBlogCandidate DevelopmentCandidate SelectionCareersClinical PharmacologyClinical Trial ManufacturingClinical Trial SuppliesColleague StoriesCommercial ManufacturingCorporate UpdatesCRDMOData SciencesDenise SuttonDennis HendersonDr. Adam Robinson-MillerDr. Andrew LewisDr. Aruna RailkarDr. Asma PatelDr. Gareth JenkinsDr. Helen BakerDr. Peter ScholesDr. Richard Castledine Dr. Stuart MairDr. Stuart McDougallDr. Vanessa ZannDrug Development ConsultingDrug ProductDrug Product OptimizationDrug Substance to Drug ProductEarly DevelopmentFirst-in-HumanFormulation DevelopmentFreeThink ASAPprimeGamma ScintigraphyGLP-1 TherapeuticsHealthy Volunteer TrialsHelen BakerHigh Potency APIsHuman ADMEIain ShawIan NisbetICP-MSIndustry CollaborationInhalationJohn EntwistleJohn McDermottKevser SevimLate DevelopmentMartin Wing-KingMiamiMicrobiologyModeling and SimulationModified ReleaseNazim KanjiNichole CaparelliNottinghamOmer AlpOncologyOrphan DrugsOrphan RarePaige BellisPediatricsPeptidesPharmacy CompoundingPhase 1 TrialsPhiladelphiaPR&DProject ManagementQuality AssuranceRare DiseasesReadingRegulatoryScientific AchievementsScientific InnovationScintigraphySite SpotlightSolid-State CharacterizationSolubility EnhancementThierry Van NieuwenhoveDrug SubstanceIntegrated ProgramsSustainabilityTranslational Pharmaceutics Publish Date View all time20252024202320222021202020192018 Fulltext search 86 - 90 of 121 results Modeling and Simulation, Clinical PharmacologySpotlight on Modeling and SimulationBy: Dr. Alison WilbyModeling and Simulation, Clinical PharmacologySpotlight on Modeling and SimulationBy: Dr. Alison WilbyLearn more Dr. Vanessa Zann, Biopharmaceutics, Early Development, Drug Product Optimization, Formulation DevelopmentWhat is the role of biopharmaceutics in early drug development?Dr. Vanessa Zann, Biopharmaceutics, Early Development, Drug Product Optimization, Formulation DevelopmentWhat is the role of biopharmaceutics in early drug development?Learn more Peptides, Dr. Andrew LewisAn integrated “make-test” approach for peptide developmentPeptides, Dr. Andrew LewisAn integrated “make-test” approach for peptide developmentLearn more 505(b)(2), Regulatory, Dr. Aruna RailkarWhat Is 505(b)(2)? Choosing a partner to accelerate the development of 505(b)(2) drug products505(b)(2), Regulatory, Dr. Aruna RailkarWhat Is 505(b)(2)? Choosing a partner to accelerate the development of 505(b)(2) drug productsLearn more Alnwick, Drug Substance, Dr. Gareth JenkinsAn introduction to Quotient Sciences - Alnwick, through the eyes of Gareth JenkinsAlnwick, Drug Substance, Dr. Gareth JenkinsAn introduction to Quotient Sciences - Alnwick, through the eyes of Gareth JenkinsLearn more Pagination First page « First Previous page ‹ Previous … Page 16 Page 17 Page 18 Page 19 Page 20 … Next page Next › Last page Last » Learn more about Quotient Sciences At a Glance We are a drug development and manufacturing accelerator for the global pharmaceutical industry. Learn More Our Locations Access directions and information about our facilities in the US & UK. Browse Locations Careers See what life is like at Quotient Sciences and how you can join our global team. Browse Jobs Get in touch Humanity can't afford to wait, so neither can we. Let's talk
